Body Composition Monitor(BCM) Guided Fluid Management in Maintenance Hemodialysis (MHD) Patients
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 433 participants.
Also called NCT01509937
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose supportive care
- Phase
- Not applicable
- Enrolled
- 433 participants
- Registry
-
NCT01509937
-
- Other papers using this trial's data
- The effect of BCM guided dry weight assessment on short-term survival in Chinese hemodialysis patients : Primary results of a randomized trial - BOdy COmposition MOnitor (BOCOMO) study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01509937. Randomized; no masking; primary purpose supportive care. Start 2013-01 (registry gives no type); primary completion 2015-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Body Composition Monitor(BCM) Guided Fluid Management in Maintenance Hemodialysis (MHD) Patients
- Acronym
- BOCOMO
- Condition
- End Stage Renal Disease
- Intervention (Device)
- body bioimpedance spectroscopy device
- Intervention (Device)
- Device
- Lead sponsor
- Peking University First Hospital
- Collaborator
- Fresenius Medical Care (Shanghai) Co., Ltd
Record details
- Record id
cardio:ct-nct01509937- Content hash
7f920a34549c2b00af1d0a9ead29eba36de4475e720e9e3b1d673c275bf45fde